Preprint · not peer-reviewed Researchers Educators

Preprint exposes training-data bias in methods used to link GWAS signals to target genes

A benchmarking preprint finds that widely used GWAS effector-gene prioritisation methods are critically dependent on the evidence type used to train them, with implications for how post-GWAS analyses inform drug target selection.

Published · AI-drafted summary based on 1 public source
Illustration for polygenic story
Illustrative image — not from the source article.
Share

A preprint posted to bioRxiv on 18 November 2026 reports a systematic benchmarking study of methods used to assign effector genes at genome-wide association study (GWAS) loci — the step that translates a statistical association signal into a candidate biological mechanism.

Approximately 90 per cent of trait-associated lead variants from GWAS lie outside protein-coding regions, making effector gene nomination a central bottleneck in translational genetics. The authors benchmarked established prioritisation methods across three independent evaluation sets and trained five domain-informed models, each anchored to a different biological line of evidence. They applied these across six common traits and found that method performance was strongly dependent on which quasi-true-positive set was used for training — a circularity risk that the authors argue is widely underappreciated in the field.

The study does not propose a single preferred method but instead argues for greater transparency about training-data assumptions in published prioritisation pipelines. The findings are particularly relevant to researchers designing post-GWAS functional follow-up studies and to those evaluating the genetic support for drug targets — a step that pharmaceutical and translational research groups routinely perform before committing resources to target validation.

As a preprint, the work has not yet been peer-reviewed. The methodological critique it raises has implications for how the field interprets the strength of genetic evidence for any given gene target.

Sources

Read the original reporting — these are the public sources this summary draws from.

  1. Primary sourcePreprint bioRxiv · 2026-11-18
    Domain-informed effector gene assignment exposes training-data dependence of drug target prioritisation from GWAS

Tags

gwas effector-gene-assignment post-gwas drug-target-validation benchmarking statistical-genetics computational-genomics preprint
Share

About Genetic Current

Educational summaries of public genetics news

Genetic Current is the news section of Evagene, an academic, research, and educational pedigree-modelling platform. Stories are AI-drafted summaries of items from trusted public sources, written for researchers, clinicians, educators, students, genealogists, and patients with an interest in genetics. Summaries are for educational and research purposes only and are not medical advice.

Join the Evagene Alpha Waiting List